MegaPro Biomedical Co., Ltd
6827
Rank in Stocks
#24095
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Share Price
$0.45574266
Last synced: 2026-11-10
Market Cap
$36.09M
Change (1 day)
-1.97%
Change (1 year)
-9.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade MegaPro Biomedical Co., Ltd (6827)
Category
Healthcare
EPS for MegaPro Biomedical Co., Ltd (6827)
EPS as of June 2026 TTM: $-0.04
According to MegaPro Biomedical Co., Ltd's latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.06, an increase over its 2024 EPS of $-0.08.
EPS history for MegaPro Biomedical Co., Ltd from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | -33.17% |
| 2025 | $-0.06 | -30.97% |
| 2024 | $-0.08 | 1.87% |
| 2023 | $-0.08 | 21.70% |
| 2022 | $-0.07 | 10.76% |
| 2021 | $-0.06 | -42.34% |
| 2020 | $-0.10 | -13.50% |
| 2019 | $-0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -39,152.37% |
US
|
|
| $-7.07 | 17,530.92% |
US
|
|
| $-5.29 | 13,092.02% |
AU
|
|
| $12.88 | -32,219.95% |
BE
|
|
| $21.56 | -53,865.59% |
NL
|
Questions about MegaPro Biomedical Co., Ltd's earnings per share (EPS)
What is MegaPro Biomedical Co., Ltd's earnings per share (EPS)?
MegaPro Biomedical Co., Ltd's earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was MegaPro Biomedical Co., Ltd's earnings per share (EPS) in 2025?
In 2025, MegaPro Biomedical Co., Ltd's earnings per share (EPS) was $-0.06, compared with $-0.08 in 2024.
How has MegaPro Biomedical Co., Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, MegaPro Biomedical Co., Ltd's earnings per share (EPS) was highest in 2025 ($-0.06) and lowest in 2020 ($-0.10).
How does MegaPro Biomedical Co., Ltd's earnings per share (EPS) compare with similar companies?
MegaPro Biomedical Co., Ltd's earnings per share (EPS) ($-0.04) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.